Thermoelectric properties and EPR analysis of Fe doped Cu12Sb4S13

Autor: Guler, A. ^a, Ballikaya, S. ^{b, ⁎}, Boyraz, C. ^c, Okay, C. ^d, Shulgin, D. ^e, Rameev, B. ^{f, g}

Publikováno v: In Journal of Solid State Chemistry January 2019 269:547-552

Developing High-Performance and Low-Cost Paint Thermoelectric Materials for Low-Midtemperature Applications.

Autor: Yilmaz M; Department of Chemical Engineering, Istanbul University-Cerrahpaşa, Avcılar 34320, Istanbul, Turkey., Yusuf A; Department of Engineering Sciences, Istanbul University-Cerrahpaşa, Avcılar 34320, Istanbul, Turkey., Gurkan K; Department of Electrical and Electronics Engineering, Istanbul University-Cerrahpaşa, Avcılar 34320, Istanbul, Turkey., Ballikaya S; Department of Engineering Sciences, Istanbul University-Cerrahpaşa, Avcılar 34320, Istanbul, Turkey.

Publikováno v: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Mar 13; Vol. 16 (10), pp. 12661-12671. Date of Electronic Publication: 2024 Mar 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Translational development of ABCB5 ⁺ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers.

Autor: Kerstan A; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany., Dieter K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Niebergall-Roth E; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Klingele S; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Jünger M; Department of Dermatology, University Hospital Greifswald, Greifswald, Germany., Hasslacher C; Clinical Study Center St. Josefskrankenhaus, Heidelberg, Germany., Daeschlein G; Department of Dermatology, University Hospital Greifswald, Greifswald, Germany.; Clinic of Dermatology, Immunology and Allergology, Medical University Brandenburg 'Theodor Fontane' Medical Center Dessau, Dessau, Germany., Stemler L; Diabetologikum DDG Ludwigshafen, Ludwigshafen, Germany., Meyer-Pannwitt U; Department of Clinical Research and Development, MARE Clinic, Kiel, Germany., Schubert K; medamed GmbH, Leipzig, Germany., Klausmann G; Studienzentrum Aschaffenburg, Aschaffenburg, Germany., Raab T; Diabetologikum Raab, Kassel, Germany., Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany., Kraft K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Esterlechner J; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Schröder HM; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Sadeghi S; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Ballikaya S; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Gasser M; Department of Surgery, University Hospital Würzburg, Würzburg, Germany., Waaga-Gasser AM; Department of Surgery, University Hospital Würzburg, Würzburg, Germany.; Division of Renal (Kidney) Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Murphy GF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Orgill DP; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Frank NY; Department of Medicine, VA Boston Healthcare System, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA., Ganss C; RHEACELL GmbH & Co. KG, Heidelberg, Germany.; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany., Scharffetter-Kochanek K; Department of Dermatology and Allergic Diseases, University Hospital, Ulm, Germany., Frank MH; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia., Kluth MA; RHEACELL GmbH & Co. KG, Heidelberg, Germany. andreas.kluth@ticeba.com.; TICEBA GmbH, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany. andreas.kluth@ticeba.com.

Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2022 Sep 05; Vol. 13 (1), pp. 455. Date of Electronic Publication: 2022 Sep 05.

Allogeneic ABCB5 ⁺ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial.

Autor: Kerstan A; Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany., Dieter K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Niebergall-Roth E; TICEBA GmbH, Heidelberg, Germany., Dachtler AK; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Kraft K; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Stücker M; Department of Dermatology, St. Josef Hospital Bochum, Ruhr University Bochum, Bochum, Germany., Daeschlein G; Department of Dermatology, University Medicine Greifswald, Greifswald, Germany., Jünger M; Department of Dermatology, University Medicine Greifswald, Greifswald, Germany., Görge T; Department of Dermatology, University Hospital Münster, Münster, Germany., Meyer-Pannwitt U; pro scientia med at the Department of Clinical Research and Development, MARE Clinic, Kiel, Germany., Erfurt-Berge C; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany., von Engelhardt C; Klinische Forschung Schwerin GmbH, Schwerin, Germany., Klare A; Klinische Forschung Hamburg GmbH, Hamburg, Germany., Pfeiffer C; Department of Dermatology and Allergic Diseases, University Hospital, Ulm, Germany., Esterlechner J; TICEBA GmbH, Heidelberg, Germany., Schröder HM; RHEACELL GmbH & Co. KG, Heidelberg, Germany., Gasser M; Department of Surgery, University Hospital Würzburg, Würzburg, Germany., Waaga-Gasser AM; Department of Surgery, University Hospital Würzburg, Würzburg, Germany.; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Goebeler M; Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany., Ballikaya S; TICEBA GmbH, Heidelberg, Germany., Sadeghi S; TICEBA GmbH, Heidelberg, Germany., Murphy GF; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Orgill DP; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Frank NY; Department of Medicine, VA Boston Healthcare System, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA., Ganss C; RHEACELL GmbH & Co. KG, Heidelberg, Germany.; TICEBA GmbH, Heidelberg, Germany., Scharffetter-Kochanek K; Department of Dermatology and Allergic Diseases, University Hospital, Ulm, Germany., Frank MH; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Transplant Research Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Kluth MA; RHEACELL GmbH & Co. KG, Heidelberg, Germany.; TICEBA GmbH, Heidelberg, Germany.

Publikováno v: JID innovations : skin science from molecules to population health [JID Innov] 2022 Jan; Vol. 2 (1). Date of Electronic Publication: 2021 Oct 25.